Immune cell proliferation

Immune cell proliferation refers to the process by which immune cells (especially T lymphocytes and B lymphocytes) multiply through cell division in response to various physiological stimuli, including infection, antigen exposure, tissue damage, or immunotherapy[1][4][10]. This process is critical for maintaining adequate immune surveillance and responses. It involves coordinated signaling through cell surface receptors (e.g., T cell receptor, cytokine receptors), intracellular signaling cascades (e.g., Ca2+, MAPK, PI3K/AKT), and tightly regulated cell cycle machinery (e.g., cyclins, CDKs, E2F)[1][3][6][9]. Dysregulated immune cell proliferation is found in diseases such as cancer, autoimmune and inflammatory disorders, and is a therapeutic target for a range of immunomodulatory drugs. However, "immune cell proliferation" itself is not a single molecular entity or drug target, but a biological process controlled by many possible targets. In summary, "immune cell proliferation" is incorrectly specified as a target; it is a biological process, not a discrete molecule, receptor, or protein. Specific molecular targets within this process include cytokine receptors (e.g., interleukin-2 receptor), cell cycle regulators (e.g., CDKs), and various intracellular signaling molecules, any of which may be individually targeted in therapeutic interventions[1][3][6][9].

Other names

Lymphocyte proliferationT cell proliferationB cell proliferation